Multiple sclerosis
Alyssa Nylander, David A Hafler, Alyssa Nylander, David A Hafler
Abstract
Multiple sclerosis (MS) is a multifocal demyelinating disease with progressive neurodegeneration caused by an autoimmune response to self-antigens in a genetically susceptible individual. While the formation and persistence of meningeal lymphoid follicles suggest persistence of antigens to drive the continuing inflammatory and humoral response, the identity of an antigen or infectious agent leading to the oligoclonal expansion of B and T cells is unknown. In this review we examine new paradigms for understanding the immunopathology of MS, present recent data defining the common genetic variants underlying disease susceptibility, and explore how improved understanding of immune pathway disruption can inform MS prognosis and treatment decisions.
Figures




Source: PubMed
Upcoming Clinical Trials
-
Kanglin Biotechnology (Hangzhou) Co., Ltd.Not yet recruitingParkinson's Disease (PD) | Advanced Primary PDChina
-
Carilion ClinicRecruiting
-
Mahidol UniversityNot yet recruitingBreast Cancer | Ductal Carcinoma In Situ
-
Biosensors Europe SANot yet recruitingNSTEMI | Unstable Angina (UA) | Angina (Stable)United Kingdom
-
CooperVision International Limited (CVIL)Not yet recruiting
-
Shanghai Yueyang Integrated Medicine HospitalRecruitingSarcopenia in ElderlyChina
-
University of Management and Technology LahoreNot yet recruitingFarward Head PosturePakistan
-
China National Center for Cardiovascular DiseasesNot yet recruitingDrug-coated Balloon | Intravascular Ultrasound | De Novo Large Coronary VesselChina
-
Korea University Anam HospitalNot yet recruitingAF - Atrial FibrillationSouth Korea
-
Jijun WangRecruiting
-
DiproBio (Shanghai) Co., Ltd.Not yet recruitingMental Health | Psychological StressChina
-
Emory UniversityNot yet recruitingPregnancy Related | Hypertensive Disorder of Pregnancy (HDP)United States